Transverse Perineal Support With STARR for Anterior Rectocele With Excessive Perineal Descent
Effect of Adding Transverse Perineal Support to Stapled Transanal Rectal Resection for Anterior Rectocele With Excessive Perineal Descent: A Randomized Controlled Trial
1 other identifier
interventional
64
1 country
1
Brief Summary
This prospective randomized controlled trial will include adult patients with ODS, anterior rectocele ≥3 cm, and excessive perineal descent following failure of conservative treatment. Patients will be randomized 1:1 to STARR alone or STARR combined with transverse perineal support procedure using polypropylene mesh. The primary outcome will be Change in Obstructed Defecation Syndrome score (ODS-S; Renzi score) in both groups. Secondary outcomes will include operative time, postoperative pain, surgical complications, surgical site infection, and sexual function assessed using the PISQ-12. Patients will be followed up twice during the first postoperative week, weekly during the first month, and monthly thereafter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2026
CompletedFirst Posted
Study publicly available on registry
August 20, 2026
CompletedStudy Start
First participant enrolled
September 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
August 26, 2026
August 1, 2026
1.3 years
August 18, 2026
August 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Obstructed Defecation Syndrome score (ODS-S; Renzi score) in both groups.
Compare Change in Obstructed Defecation Syndrome score (ODS-S; Renzi score) in both groups. Obstructed Defecation Syndrome score (ODS-S; Renzi score) ranges from 0 to 20. Higher scores indicate a worse outcome (more severe obstructed defecation symptoms )
Up to 6 months postoperatively
Secondary Outcomes (6)
Operative time
During surgery
Number of participants with surgical site infection
Up to 6 months postoperatively
Postoperative urine retention
Within 48 hours postoperatively
Pain intensity
Up to 6 months postoperatively
Sexual Function in both groups
Up to 6 months postoperatively
- +1 more secondary outcomes
Study Arms (2)
STARR procedure
ACTIVE COMPARATORSTARR will be done using PPH circular stapler to achieve trans-anal full-thickness resection of the rectocele
STARR combined with transverse perineal support procedure
EXPERIMENTALTransverse perineal support procedure will be added to the STARR procedure. Transverse perineal support procedure will be done using a non-absorbable polypropylene mesh to reinforce the perineal body and correct excessive perineal descent.
Interventions
The STARR procedure will be performed using PPH circular stapler to achieve trans-anal full-thickness resection of the rectocele
Transverse perineal support procedure will be added to STARR procedure. it will be done using a non-absorbable polypropylene mesh to reinforce the perineal body and correct excessive perineal descent.
Eligibility Criteria
You may qualify if:
- Adult patients complaining of obstructed defecation syndrome with anterior rectocele ≥ 3 cm associated with excessive perineal descent with failure of conservative management.
You may not qualify if:
- Patients with Slow-transit constipation
- Patients with anterior rectocele of \< 3 cm
- Patients with complete external rectal prolapse
- Evidence of colorectal carcinoma or Inflammatory bowel disease ( IBD)
- Inability for lifestyle change postoperatively
- Patients with fecal incontinence
- Previous surgeries for anterior rectocele
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of medicine, Cairo University
Cairo, Al-Manial, Cairo, Egypt, Egypt, 11451, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Haitham M.Azmy Basiouny, MD
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
August 18, 2026
First Posted
August 20, 2026
Study Start
September 2, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Last Updated
August 26, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because this is a small surgical trial with a limited number of participants, and sharing raw data could lead to identification of participants